Bone Biologics Corp 10-Q filing
Filed 2026-05-14 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001493152-26-023163
- Form type
- 10-Q
- CIK
- 0001419554
- Primary document
- https://www.sec.gov/Archives/edgar/data/1419554/000149315226023163/form10-q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Bone Biologics Corp.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-805,054 | - | - |
| Net Income | $-765,988 | - | - |
| Eps Basic | -0.43 | - | - |
| Eps Diluted | -0.43 | - | - |
| Total Assets | $5.0M | - | - |
| Total Liabilities | $309,386 | - | - |
| Shareholders Equity | $4.7M | - | - |
| Operating Cash Flow | $-804,282 | - | - |